Navigation Links
Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
Date:7/10/2012

LONDON, July 11, 2012 /PRNewswire/ -- Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1. The study demonstrated superiority of the dolutegravir-based regimen compared to the single tablet regimen Atripla®.  At 48 weeks, 88% of study participants on the dolutegravir regimen were virologically suppressed (<50 copies/mL) vs. 81% of participants on the single tablet regimen Atripla [difference and 95% CI; 7.4% (+2.5% to +12.3%); difference in the primary endpoint was statistically significant, p=0.003]. Differences in efficacy were primarily driven by a higher rate of discontinuation due to adverse events on the Atripla arm. The SINGLE study was designed to demonstrate non-inferiority of the dolutegravir-based regimen versus Atripla, and the primary analysis met this criterion.  Statistical superiority was concluded as part of a subsequent, pre-specified testing procedure.

SINGLE is an ongoing double blind, double dummy study designed to compare the efficacy and safety of two antiretroviral regimens: dolutegravir 50mg plus abacavir/lamivudine (Kivexa®/Epzicom®) versus Atripla® (tenofovir/emtricitabine/efavirenz). The primary endpoint was the proportion of study participants with undetectable HIV-1 RNA (<50c/mL) at 48 weeks; 414 treatment-naive study participants were randomised and exposed to the dolutegravir-based  regimen and 419 to the Atripla arm.  Overall, 2% of subjects on the dolutegravir-based regimen discontinued due to adverse events vs. 10% of those receiving the Atripla regimen. The most common drug related adverse events on Atripla were in the nervous system System Organ Class (reported by 41% of Atripla recipients, vs. 15% of participants receiving the dolutegravir-based regimen), while the most common drug relat
'/>"/>

SOURCE Shionogi-ViiV Healthcare LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... March 21, 2011 CCS Medical today announced that its ... Executive Officer for CCS Medical effective immediately.  Mr. Allison has ... "I am very excited about joining CCS Medical ... have positioned ourselves well in our markets and I look ...
... PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: ... medical technology for treating cancer with radiotherapy, will showcase ... radiosurgery at the 23rd International Medical Instruments and Equipment ... TrueBeam was designed from the ground up to treat ...
Cached Medicine Technology:Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing 2Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing 3
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... transmits data from the human body could boost British ... the wearers ear, the sensor is unique in two ... can gather unprecedentedly wide-ranging and useful data about posture, ... travelling through the body etc. , Second, when worn ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... the consumer and professional markets, announced,today the successful ... CTEC ). Inverness completed the acquisition through the,merger ... Cholestech, after,Cholestech,s shareholders approved the deal at a ...
... Sept. 12 AtriCure, Inc.,(Nasdaq: ATRC ), a ... cardiac surgical devices, announced,today that David J. Drachman, President ... ThinkEquity Partners 5th Annual Growth,Conference at the St. Regis ... 8:30 a.m. PT. A live web cast and ...
... Calif., Sept. 12 ,Healthcare workers at Tenet hospitals ... address Tenet,s refusal to work with frontline healthcare,workers ... joined by local,community supporters including elected officials. ... Regional,Medical Center in Palm Springs, Garden Grove Hospital, ...
... /PRNewswire-FirstCall/ - Transition Therapeutics Inc.,("Transition" or the ... developing therapeutics for disease indications,with large markets, ... year,ended June 30, 2007. Selected Highlights ... up to the date of this press ...
... Working with Sow the Seeds Fund and Sustain to Raise ... ... in late,August have led to the decimation of a number of ... has joined a,remarkable collaboration of farmers, nonprofits, restaurants and natural,food cooperatives ...
Cached Medicine News:Health News:Leading-edge body sensor could help produce sporting champions 2Health News:Inverness Completes Acquisition of Cholestech 2Health News:Inverness Completes Acquisition of Cholestech 3Health News:AtriCure to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:Healthcare Workers Rally to Address Concerns About Layoffs and Quality Patient Care 2Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 2Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 3Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 4Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 5Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 6Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 7Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 8Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 9Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 10Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 11Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 12Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 13Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 14Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 15Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 16Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 17Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 18Health News:Transition Therapeutics Announces Fiscal 2007 Year End Financial Results 19Health News:Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations 2Health News:Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations 3
... special order products are offered as 1-piece ... lengths. The modular instruments may be customized ... such as ratchets, insulation and flush ports. ... stock. Customer specifications may affect delivery times. ...
Disposable sheath for use with 5mm AEM Laparoscopic Instruments ....
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: